Item2
|
Control
|
CP
|
L-LJ
|
H-LJ
|
Pooled SE
|
P-value
|
---|
C14:0
|
24.4c
|
28.14a
|
26.24b
|
25.55bc
|
0.33
|
<0.001
|
C16:0
|
724.7
|
771.2
|
759.2
|
758.1
|
7.38
|
0.136
|
C16:1n-7
|
131.2
|
140.6
|
133.5
|
135.8
|
2.22
|
0.495
|
C18:0
|
311.9
|
341.2
|
340.7
|
329.5
|
5.22
|
0.158
|
C18:2n-6
|
909.4
|
862.4
|
888.2
|
884.3
|
11.91
|
0.594
|
C18:3n-3 (α-LA)
|
35.71a
|
31.22c
|
32.81b
|
33.92ab
|
0.45
|
0.002
|
C20:2n-6
|
14.91
|
14.27
|
14.29
|
15.01
|
0.16
|
0.220
|
C20:4n-6
|
111.8a
|
88.24c
|
91.21bc
|
99.34b
|
2.07
|
<0.001
|
C20:5n-3 (EPA)
|
9.99a
|
6.28c
|
7.91b
|
8.22b
|
0.22
|
<0.001
|
C22:4n-6
|
19.71a
|
15.27b
|
15.98b
|
16.29b
|
0.38
|
<0.001
|
C22:5n-3
|
33.91a
|
27.57b
|
29.33b
|
29.77b
|
0.47
|
<0.001
|
C22:6n-3 (DHA)
|
7.07a
|
6.02b
|
6.55ab
|
6.93a
|
0.12
|
0.004
|
Total SFA
|
1297b
|
1455a
|
1391ab
|
1329b
|
18.16
|
0.008
|
Total MUFA
|
1301
|
1202
|
1255
|
1257
|
17.38
|
0.250
|
Total PUFA
|
1,008a
|
901.5c
|
951.2bc
|
977.3b
|
12.94
|
0.022
|
n-6 PUFA
|
917.4
|
878.6
|
899.6
|
901.4
|
9.56
|
0.571
|
n-3 PUFA
|
81.21a
|
67.07c
|
74.31b
|
75.29b
|
0.99
|
<0.001
|
PUFA:SFA ratio
|
0.78a
|
0.62c
|
0.68bc
|
0.74ab
|
0.02
|
0.002
|
n-6:n-3 ratio
|
11.30b
|
13.10a
|
12.11b
|
11.97b
|
0.19
|
0.004
|
-
a,bMeans in the same row with different superscripts are significantly different. (P < 0.05)
-
1control = basal diet + PBS; CP = basal diet + CP administration; L-LJ = basal diet with 1.0 × 105 cfu BS15/g diet + CP administration; H-LJ = basal diet with 1.0 × 106 cfu BS15/g diet + CP administration
-
1n = 12 per treatment group
-
2
SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid